Evidence item

The packet directly supports the sample, intention-to-treat comparison, per-protocol result, and absence of serious adverse events. DATASET_RESULT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 17983

Source: Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial · locator {} · excerpt hash sha256:a0f0ea63c7f447a18c6b4058b806e8c4b71a45f19d380b7df0cc2fc4d4ec470a

Exact excerpt

In ITT, initial cure rates were 44.0% (n = 40) for TT and 52.2% (n = 48) for IL-SSG V, demonstrating no statistically significant difference (p = 0.266). Final cure rates were 34.1% (n = 31) for TT and 43.5% (n = 40) for IL-SSG V (p = 0.191). In PP analysis, the final cure rate was 39.2% in the TT and 57.6% in the IL-SSG arm, showing a statistically significant difference (p = 0.032). No serious adverse events were reported.

Linked claims

Claim	Direction	Relevance	Steps	Counted
0acba021	SUPPORT	DIRECT	0	yes

Audits

None.